These results are not only consistent with recently published data showing reduced AAA formation in β-arrestin-2–/– mice upon AngII stimulation,63 but also delineate a landscape in depth with its clinical relevance, in vivo regulatory mechanism, detailed structural basis and pharmacological characterization of biased AT1 signaling regulated by COMP, an endogenous biased modulator. Here, COMP is linked to triple-A syndrome.